Revelation Biosciences News

DEF 14A: Definitive information statements

Apr 16 12:47 ET

Revelation Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 5 16:05 ET

Revelation Biosciences | 8-K: Current report

Mar 22 16:31 ET

Revelation Biosciences | 10-K: Annual report

Mar 22 16:03 ET

Revelation Biosciences | 8-K: Current report

Mar 12 06:07 ET

Revelation Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(2.9%),Lind Global Partners II LLC(2.9%), etc.

Feb 13 20:16 ET

Revelation Biosciences | SCHEDULE 13G/A: Others

Feb 12 10:24 ET

Revelation Biosciences | 8-K: Current report

Feb 8 16:06 ET

Revelation Biosciences | 424B3: Prospectus

Feb 2 16:13 ET

Revelation Biosciences | EFFECT: Others

Feb 1 06:11 ET

Revelation Biosciences | 8-K: Current report

Jan 30 17:24 ET

Revelation Biosciences | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jan 30 15:38 ET

Revelation Biosciences | CORRESP: CORRESP

Jan 30 11:34 ET

Revelation Biosciences | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jan 29 17:35 ET

Revelation Biosciences | CORRESP: CORRESP

Jan 29 11:34 ET

Revelation Biosciences | 8-K: Current report

Jan 23 00:00 ET

Revelation Biosciences | 8-K: Current report

Jan 22 00:00 ET

Revelation Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals

Jan 3 00:00 ET

Revelation Biosciences | UPLOAD: Others

Jan 2 11:34 ET

Revelation Biosciences | DEF 14A: Definitive information statements

Dec 22, 2023 17:06 ET